Company intelligence / Profile preview

PetaGene

Cambridge, United Kingdom

Ownership: Private
Employees: ~11
Development stage: Other

Overview

PetaGene developed software for lossless compression and encryption of genomic data (BAM and FASTQ formats), enabling 60-90% reductions in storage and transfer costs while maintaining data quality and compatibility with existing tools. Acquired by Storj Labs in October 2024.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

NVIDIAAstraZenecaDell TechnologiesAlliance GlobalGenique Lifesciences

Beyond the preview

Go deeper on PetaGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PetaGene.

Explore the full profile